human chorionic gonadotropin (h CG)
GPTKB entity
Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:item
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:embryonal_carcinoma
|
| gptkbp:appointed_by |
gptkb:healthcare_organization
pregnant women injection hypogonadism |
| gptkbp:can_be |
trophoblastic disease
|
| gptkbp:caused_by |
nausea and vomiting
|
| gptkbp:composed_of |
alpha and beta subunits
|
| gptkbp:enhances |
corpus luteum
testosterone production |
| gptkbp:established |
follicle-stimulating hormone (FSH) secretion
|
| gptkbp:function |
pregnancy
|
| gptkbp:has_role |
embryo development
|
| https://www.w3.org/2000/01/rdf-schema#label |
human chorionic gonadotropin (h CG)
|
| gptkbp:increased |
first trimester
|
| gptkbp:is_a |
glycoprotein hormone
|
| gptkbp:is_associated_with |
multiple pregnancies
h CG levels h CG receptor |
| gptkbp:is_involved_in |
gptkb:spermatogenesis
placental development hormonal regulation fertility treatments ovulation induction hormonal signaling pathways hormonal feedback loops |
| gptkbp:is_linked_to |
pregnancy complications
ovarian hyperstimulation syndrome h CG-related disorders |
| gptkbp:is_part_of |
reproductive system
|
| gptkbp:is_related_to |
gptkb:gestational_trophoblastic_neoplasia
h CG antibodies |
| gptkbp:is_used_for |
weight loss programs
monitoring treatment efficacy male infertility pregnancy tests diagnosing pregnancy monitoring fetal health |
| gptkbp:is_used_in |
gptkb:healthcare_organization
clinical trials hormone replacement therapy surgical procedures IVF procedures |
| gptkbp:measures |
blood tests
fertility assessments monitoring pregnancy |
| gptkbp:produced_by |
gptkb:embryo
placenta early pregnancy implantation |
| gptkbp:recognizes |
urine
|
| gptkbp:reduces |
second trimester
|
| gptkbp:regulates |
steroid hormones
|
| gptkbp:security_features |
syncytiotrophoblasts
|
| gptkbp:used_in |
diagnosis of ectopic pregnancy
|
| gptkbp:weight |
approximately 36 k Da
|